aripiprazole

FDA Drug Profile — ARIPIPRAZOLE, aripiprazole, ABILIFY MAINTENA

aripiprazole is listed in the FDA National Drug Code directory with 60 NDC codes, marketed under brand names including ARIPIPRAZOLE, aripiprazole, ABILIFY MAINTENA. Available dosage forms: tablet, injection, powder, lyophilized, for suspension, extended release, kit, solution.

Drug details

Generic Name
aripiprazole
Brand Names
ARIPIPRAZOLE, aripiprazole, ABILIFY MAINTENA
Application Number
ANDA205363
Sponsor
Solco Healthcare U.S., LLC
NDC Codes
60
Dosage Forms
TABLET, INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE, KIT, SOLUTION
Routes
ORAL
Active Ingredients
ARIPIPRAZOLE

Indications and Usage

1 INDICATIONS AND USAGE Aripiprazole tablets are indicated for the treatment of: Schizophrenia Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder Irritability Associated with Autistic Disorder Treatment of Tourette’s Disorder Aripiprazole is an atypical antipsychotic. Aripiprazole tablets are indicated for: Schizophrenia ( 14.1 ) Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder ( 14.2 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette’s Disorder ( 14.5 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.